» Articles » PMID: 10793060

Regulation of Tissue Injury Responses by the Exposure of Matricryptic Sites Within Extracellular Matrix Molecules

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2000 May 4
PMID 10793060
Citations 159
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular matrix (ECM) is known to provide signals controlling cell shape, migration, proliferation, differentiation, morphogenesis, and survival. Recent data shows that some of these signals are derived from biologically active cryptic sites within matrix molecules (matricryptic sites) that are revealed after structural or conformational alteration of these molecules. We propose the name, matricryptins, for enzymatic fragments of ECM containing exposed matricryptic sites. Mechanisms regulating the exposure of matricryptic sites within ECM molecules include the major mechanism of enzymatic breakdown as well as others including ECM protein multimerization, adsorption to other molecules, cell-mediated mechanical forces, and ECM denaturation. Such matrix alterations occur during or as a result of tissue injury, and thus, the appearance of matricryptic sites within an injury site may provide important new signals to regulate the repair process. Here, we review the data supporting this concept and provide insight into why the increased exposure of matricryptic sites may be an important regulatory step in tissue responses to injury.

Citing Articles

Research Progress on Extracellular Matrix-Based Composite Materials in Antibacterial Field.

Cai D, Liu T, Weng W, Zhu X Biomater Res. 2025; 29():0128.

PMID: 39822928 PMC: 11735711. DOI: 10.34133/bmr.0128.


Effects of the matrix-bounded nanovesicles of high-hydrostatic pressure decellularized tissues on neural regeneration.

Kobayashi M, Negishi J, Ishida N, Hashimoto Y, Sasaki Y, Akiyoshi K Sci Technol Adv Mater. 2024; 25(1):2404380.

PMID: 39308888 PMC: 11413956. DOI: 10.1080/14686996.2024.2404380.


Diverse and multifunctional roles for perlecan () in repair of the intervertebral disc.

Melrose J, Guilak F JOR Spine. 2024; 7(3):e1362.

PMID: 39081381 PMC: 11286675. DOI: 10.1002/jsp2.1362.


Involvement of Matricellular Proteins in Cellular Senescence: Potential Therapeutic Targets for Age-Related Diseases.

Fujita M, Sasada M, Iyoda T, Fukai F Int J Mol Sci. 2024; 25(12).

PMID: 38928297 PMC: 11204155. DOI: 10.3390/ijms25126591.


The Versatility of Collagen in Pharmacology: Targeting Collagen, Targeting with Collagen.

Revert-Ros F, Ventura I, Prieto-Ruiz J, Hernandez-Andreu J, Revert F Int J Mol Sci. 2024; 25(12).

PMID: 38928229 PMC: 11203716. DOI: 10.3390/ijms25126523.


References
1.
SPANGLER B . Binding to native proteins by antipeptide monoclonal antibodies. J Immunol. 1991; 146(5):1591-5. View

2.
Falcone D, Mated N, Shio H, Minick C, Fowler S . Lipoprotein-heparin-fibronectin-denatured collagen complexes enhance cholesteryl ester accumulation in macrophages. J Cell Biol. 1984; 99(4 Pt 1):1266-74. PMC: 2113294. DOI: 10.1083/jcb.99.4.1266. View

3.
Brooks P, Clark R, Cheresh D . Requirement of vascular integrin alpha v beta 3 for angiogenesis. Science. 1994; 264(5158):569-71. DOI: 10.1126/science.7512751. View

4.
Davis G . Affinity of integrins for damaged extracellular matrix: alpha v beta 3 binds to denatured collagen type I through RGD sites. Biochem Biophys Res Commun. 1992; 182(3):1025-31. DOI: 10.1016/0006-291x(92)91834-d. View

5.
Senger D, Asch B, Smith B, Perruzzi C, Dvorak H . A secreted phosphoprotein marker for neoplastic transformation of both epithelial and fibroblastic cells. Nature. 1983; 302(5910):714-5. DOI: 10.1038/302714a0. View